Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya

The COVID-19 pandemic has significantly impacted healthcare systems, including antibiotic use practices. We present data on patterns of antibiotic dispensing and use in community and hospital settings respectively in Nairobi, Kenya during the pandemic. We conducted interviews with 243 pharmacies in...

Descripción completa

Detalles Bibliográficos
Autores principales: Gacheri, June, Hamilton, Katie A., Munywoki, Peterkin, Wakahiu, Sinaida, Kiambi, Karen, Fèvre, Eric M., Oluka, M.N., Guantai, E.M., Moodley, Arshnee, Muloi, Dishon M.
Formato: Journal Article
Lenguaje:Inglés
Publicado: 2024
Materias:
Acceso en línea:https://hdl.handle.net/10568/141627
_version_ 1855528684313640960
author Gacheri, June
Hamilton, Katie A.
Munywoki, Peterkin
Wakahiu, Sinaida
Kiambi, Karen
Fèvre, Eric M.
Oluka, M.N.
Guantai, E.M.
Moodley, Arshnee
Muloi, Dishon M.
author_browse Fèvre, Eric M.
Gacheri, June
Guantai, E.M.
Hamilton, Katie A.
Kiambi, Karen
Moodley, Arshnee
Muloi, Dishon M.
Munywoki, Peterkin
Oluka, M.N.
Wakahiu, Sinaida
author_facet Gacheri, June
Hamilton, Katie A.
Munywoki, Peterkin
Wakahiu, Sinaida
Kiambi, Karen
Fèvre, Eric M.
Oluka, M.N.
Guantai, E.M.
Moodley, Arshnee
Muloi, Dishon M.
author_sort Gacheri, June
collection Repository of Agricultural Research Outputs (CGSpace)
description The COVID-19 pandemic has significantly impacted healthcare systems, including antibiotic use practices. We present data on patterns of antibiotic dispensing and use in community and hospital settings respectively in Nairobi, Kenya during the pandemic. We conducted interviews with 243 pharmacies in Nairobi using a standardised questionnaire from November to December 2021. The data collected included demographic characteristics, antibiotic customers, types of antibiotics sold, and antibiotic prescribing practices. Additionally, we retrospectively reviewed health records for 992 and 738 patients admitted in COVID-19 and general wards at two large inpatient hospitals between April 2020 and May 2021, and January 2019 to October 2021, respectively. Demographic, utilisation of laboratory services, treatment, clinical, and outcome data were collected using a modified Global WHO Point Prevalence Surveys (Global-PPS) tool. Almost all pharmacies (91.4%) served customers suspected of having COVID-19 with a mean weekly number of 15.6 customers. All pharmacies dispensed antibiotics, mainly azithromycin and beta lactams to suspected COVID-19 infected customers. 83.4% of hospitalised COVID-19 patients received at least one antibiotic at some point during their hospitalisation, which was significantly higher than the 53.8% in general ward patients (p<0.001). Similarly, the average number of antibiotics administered to COVID-19 patients was higher than that of patients in the general ward (1.74 vs 0.9). Azithromycin and ceftriaxone were the most commonly used antibiotics in COVID-19 patients compared to ceftriaxone and metronidazole in the general wards. Only 2% of antibiotic prescriptions for COVID-19 patients were supported by microbiological investigations, which was consistent with the proportion of 6.8% among the general ward population. Antibiotics were commonly prescribed to customers and patients suspected of having COVID-19 either in community pharmacies or in hospital, without a prescription or laboratory diagnosis. These findings emphasize the crucial role of antibiotic stewardship, particularly in community pharmacies, in the context of COVID-19.
format Journal Article
id CGSpace141627
institution CGIAR Consortium
language Inglés
publishDate 2024
publishDateRange 2024
publishDateSort 2024
record_format dspace
spelling CGSpace1416272025-10-26T12:52:33Z Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya Gacheri, June Hamilton, Katie A. Munywoki, Peterkin Wakahiu, Sinaida Kiambi, Karen Fèvre, Eric M. Oluka, M.N. Guantai, E.M. Moodley, Arshnee Muloi, Dishon M. antimicrobial resistance covid-19 health The COVID-19 pandemic has significantly impacted healthcare systems, including antibiotic use practices. We present data on patterns of antibiotic dispensing and use in community and hospital settings respectively in Nairobi, Kenya during the pandemic. We conducted interviews with 243 pharmacies in Nairobi using a standardised questionnaire from November to December 2021. The data collected included demographic characteristics, antibiotic customers, types of antibiotics sold, and antibiotic prescribing practices. Additionally, we retrospectively reviewed health records for 992 and 738 patients admitted in COVID-19 and general wards at two large inpatient hospitals between April 2020 and May 2021, and January 2019 to October 2021, respectively. Demographic, utilisation of laboratory services, treatment, clinical, and outcome data were collected using a modified Global WHO Point Prevalence Surveys (Global-PPS) tool. Almost all pharmacies (91.4%) served customers suspected of having COVID-19 with a mean weekly number of 15.6 customers. All pharmacies dispensed antibiotics, mainly azithromycin and beta lactams to suspected COVID-19 infected customers. 83.4% of hospitalised COVID-19 patients received at least one antibiotic at some point during their hospitalisation, which was significantly higher than the 53.8% in general ward patients (p<0.001). Similarly, the average number of antibiotics administered to COVID-19 patients was higher than that of patients in the general ward (1.74 vs 0.9). Azithromycin and ceftriaxone were the most commonly used antibiotics in COVID-19 patients compared to ceftriaxone and metronidazole in the general wards. Only 2% of antibiotic prescriptions for COVID-19 patients were supported by microbiological investigations, which was consistent with the proportion of 6.8% among the general ward population. Antibiotics were commonly prescribed to customers and patients suspected of having COVID-19 either in community pharmacies or in hospital, without a prescription or laboratory diagnosis. These findings emphasize the crucial role of antibiotic stewardship, particularly in community pharmacies, in the context of COVID-19. 2024-04-25 2024-04-26T12:32:06Z 2024-04-26T12:32:06Z Journal Article https://hdl.handle.net/10568/141627 en Open Access Gacheri, J., Hamilton, K.A., Munywoki, P., Wakahiu, S., Kiambi, K., Fèvre, E.M., Oluka, M.N., Guantai, E.M., Moodley, A. and Muloi, D.M. 2024. Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya. PLOS Global Public Health 4(4): e0003046.
spellingShingle antimicrobial resistance
covid-19
health
Gacheri, June
Hamilton, Katie A.
Munywoki, Peterkin
Wakahiu, Sinaida
Kiambi, Karen
Fèvre, Eric M.
Oluka, M.N.
Guantai, E.M.
Moodley, Arshnee
Muloi, Dishon M.
Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya
title Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya
title_full Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya
title_fullStr Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya
title_full_unstemmed Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya
title_short Antibiotic prescribing practices in community and clinical settings during the COVID-19 pandemic in Nairobi, Kenya
title_sort antibiotic prescribing practices in community and clinical settings during the covid 19 pandemic in nairobi kenya
topic antimicrobial resistance
covid-19
health
url https://hdl.handle.net/10568/141627
work_keys_str_mv AT gacherijune antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT hamiltonkatiea antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT munywokipeterkin antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT wakahiusinaida antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT kiambikaren antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT fevreericm antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT olukamn antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT guantaiem antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT moodleyarshnee antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya
AT muloidishonm antibioticprescribingpracticesincommunityandclinicalsettingsduringthecovid19pandemicinnairobikenya